Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0000905148-20-000747

Options or other derivatives

  • Director acquired 5,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
ROCKLAGE SCOTT M Director 2020-06-30 Grant or award · Stock Option (right to Buy) +5,600 5,600 D: show line 1 in the form
Loading xslF345X03/form4.xml…